Member Info for Laura2022

Looks

Straight

Ridiculous comment, they have loads of cash

Looks clear now

Each average contract has been £100-200k under Pete S

Therefore could be in for a great 6mths

Also cahs makes up more than half the current market cap

Nearly 6 weeks and you still haven't taken responsibility for that awful TCF tip that is now 80% down and CEO £300k salary (PYC £70) and utterly diluted

Go away

KingH

Just look at the posting history of Avocet, sushi and Jaari888

Says everything

As shown in presentations , PYC have some of lowest salaries on AIM and one of smallest shares in issue (300mlm v 1bln+)

Unlike a lot of the trough feeders

3 green boxes already

Tier 1 I assume could mean AstraZeneca etc ?

Dr Peter Sargent, CEO, commented:

"We are delighted to be awarded this contract. Not only is this contract with a brand new client, but is also in the area of ADCs; a hot new area of oncology treatments. This reflects the Company's strategy to diversify

More to come as shown in presentation

91 "warm leads" which means discussions taken place

16 active - ( specifc contract focus)

9 at proposal stage (announcedshortly)....some with Tier 1 companies

Expecting "very strong " H2 and beyond to 2026

Full year revs if hit will be 30% increase on 2024

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is delighted to announce a contract award with a new UK-based biotech company developing antibody drug conjugates (ADCs) based therapies targeting hard-to-treat cancers.

This new project will see the Company develop a Pharmacokinetic (PK) Pharmacodynamic (PD) model to inform optimal dosing for the client's upcoming First-in-Human trial. The project is valued at £102,000 and is projected to run from April 2025 until August 202

2nd and 3rd on list are the founders /BOD

I think some of these are adding ( such as the grey trades at 1pence on firiday )

As at 2 January 2025, significant beneficial shareholders holding 3%+ of issued capital are:

Holder%

Mr V Pereira*16.90%

Mr JM Rushton-Turner28.13%

Mr B Geary27.72%

Mr M Lloyd8.94%

Killik & Co LLP5.08%

Hunky

Hadron finished 2 weeks ago, see the post i did showing their last trade with last 3 numbers matching their large 80mln holding

Certainly looks good

I've been buying from 0.30p for last 6 weeks

The Scheme is conditional, among other things, upon:

(a)    the passing of all Resolutions to be proposed at (i) the First General Meeting and (ii) the Second General Meeting (or at any adjournments thereof) and upon any conditions of such Resolutions being fulfilled;

(b)    the FCA agreeing to amend the listing of the Ordinary Shares to reflect their reclassification as Reclassified Shares for the purpose of implementing the Scheme; and

(c)    the Directors resolving to proceed with the Scheme.

In the event that any of the conditions referred to in (a)(i) or (b) above fails, the Second General Meeting will be adjourned indefinitely and the Scheme will lapse.

Sub-Fund

The Sub-Fund is an open-ended investment fund which aims to achieve capital growth over the long term, by investing in an actively managed portfolio with a minimum of 70 per cent. of its assets in shares of smaller companies incorporated or domiciled in the UK. The Sub-Fund may also invest up to 30 per cent. of its assets in larger companies incorporated or domiciled in the UK as well as listed securities in other geographical regions.

Please refer to Part 3 of the Circular for further details on the Sub-Fund, including details of the investment objective and 

The Miton vote is early April regarding orderly wind up of fund

IES not showing anymore?

https://www.mitonukmicrocaptrust.com/portfolio-information/

I bought via Hargreaves Landsdowne (HL)